| 000 | 01479 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250517235501.0 | ||
| 264 | 0 | _c20190225 | |
| 008 | 201902s 0 0 eng d | ||
| 022 | _a1873-7064 | ||
| 024 | 7 |
_a10.1016/j.neuropharm.2018.09.001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGustafsson, Sofia | |
| 245 | 0 | 0 |
_aBlood-brain barrier integrity in a mouse model of Alzheimer's disease with or without acute 3D6 immunotherapy. _h[electronic resource] |
| 260 |
_bNeuropharmacology _c12 2018 |
||
| 300 |
_a1-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAlzheimer Disease _xmetabolism |
| 650 | 0 | 4 |
_aAmyloid beta-Protein Precursor _xgenetics |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Murine-Derived _xadministration & dosage |
| 650 | 0 | 4 |
_aBlood-Brain Barrier _xmetabolism |
| 650 | 0 | 4 | _aCapillary Permeability |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunotherapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aMice, Transgenic |
| 700 | 1 | _aGustavsson, Tobias | |
| 700 | 1 | _aRoshanbin, Sahar | |
| 700 | 1 | _aHultqvist, Greta | |
| 700 | 1 | _aHammarlund-Udenaes, Margareta | |
| 700 | 1 | _aSehlin, Dag | |
| 700 | 1 | _aSyvänen, Stina | |
| 773 | 0 |
_tNeuropharmacology _gvol. 143 _gp. 1-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.neuropharm.2018.09.001 _zAvailable from publisher's website |
| 999 |
_c28821760 _d28821760 |
||